TCR, Vbeta3 (T Cell Receptor V-beta-3, TCR V-beta-3)

580 EUR

100ug

GEN645740

N/A

N/A

N/A

N/A

cell

5C95

IgG2a,l

Antibodies

Monoclonal

TCR, Vbeta3

Mnoclonal antibodies

Mouse (Mus musculus)

Human (Homo sapiens)

Flow Cytometry (FC/FACS)

T cell receptor beta chain Vbeta3 domain, partial; N/A

Affinity Purified by Protein A affinity chromatography.

Supplied as a liquid in 50mM sodium phosphate, pH 7.5, 100mM potassium chloride, 150mM sodium chloride. No preservative added.

Human (Homo sapiens); Due to limited knowledge and inability for testing each and every species, the reactivity of the antibody may extend to other species which are not listed hereby.

Store the antibody at +4 degrees Celsius for short term storage.. Aliquot to avoid repeated freezing and thawing. For optimal long term storage, the antibody should be kept at -20 degrees Celsius. Aliquots are stable for 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

Recognizes human TCR V beta 3. Specific for the human V3 TCR gene product and reacts with 1-10% of T cells in normal human blood. This antibody is mitogenic for T cells expressing TCR V3.; Since it is not possible to test each and every species our knowledge on the corss reactivity of the antibodies is limited. This particular antibody might cross react with speacies outside of the listed ones.

For cells, cell lines and tissues in culture till half confluency.The receptors are ligand binding factors of type 1, 2 or 3 and protein-molecules that receive chemical-signals from outside a cell. When such chemical-signals couple or bind to a receptor, they cause some form of cellular/tissue-response, e.g. a change in the electrical-activity of a cell. In this sense, am olfactory receptor is a protein-molecule that recognizes and responds to endogenous-chemical signals, chemokinesor cytokines e.g. an acetylcholine-receptor recognizes and responds to its endogenous-ligand, acetylcholine. However, sometimes in pharmacology, the term is also used to include other proteins that are drug-targets, such as enzymes, transporters and ion-channels.